基本统计
| CIK | 1597426 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Lombard Medical, Inc.
SEC Filings (Chronological Order)
本页提供了美国证券交易委员会（SEC）备案的完整、按时间顺序排列的列表，不包括我们在其他地方提供的所有权备案。
| April 26, 2018 |
EVAR / Lombard Medical, Inc. FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of April 2018 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant’s Name into English) Cayman Isla |
|
| March 7, 2018 |
FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-10.5 Exhibit 10.5 FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS FOURTH AMENDMENT to Loan and Security Agreement (this “Amendment”) is entered into as of January 31, 2018 (the “Fourth Amendment Date”), by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (in its individual capacity, “Oxford”; a |
|
| March 7, 2018 |
FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-10.6 Exhibit 10.6 FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS FIFTH AMENDMENT to Loan and Security Agreement (this “Amendment”) is entered into as of February 28, 2018 (the “Fifth Amendment Date”), by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (in its individual capacity, “Oxford”; and |
|
| March 7, 2018 |
EVAR / Lombard Medical, Inc. 6-K (Current Report of Foreign Issuer) 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2018 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant’s Name into English) Cayman Islands ( |
|
| January 17, 2018 |
EVAR / Lombard Medical, Inc. FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 16, 2018 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands (State |
|
| January 12, 2018 |
EVAR / Lombard Medical, Inc. FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 8, 2018 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands (State o |
|
| November 9, 2017 |
EVAR / Lombard Medical, Inc. FORM 25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-36402 Lombard Medical, Inc.; The Nasdaq Capital Market (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) Lomb |
|
| October 31, 2017 |
Lombard Medical Reports First Half and Third Quarter 2017 Financial Results Exhibit 99.1 Lombard Medical Reports First Half and Third Quarter 2017 Financial Results OXFORDSHIRE, U.K.-(BUSINESS WIRE)-October 31, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAA), today reported unaudited year-to-date financial results for the first nine months ended September 30, 2017. 2017 Operati |
|
| October 31, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 October 31, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applica |
|
| October 30, 2017 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 October 26, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 No |
|
| October 30, 2017 |
Lombard Medical Announces Shares to Trade on OTCQX EX-99.1 2 d453557dex991.htm EX-99.1 Exhibit 99.1 Lombard Medical Announces Shares to Trade on OTCQX Oxfordshire, UK – October 30, 2017 – Lombard Medical, Inc. (Nasdaq: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAA), today announced that it has notified Nasdaq of its intention to voluntarily delist the Company’s shares from the Nasdaq Cap |
|
| October 19, 2017 |
EX-10.6 Exhibit 10.6 STRICTLY PRIVATE AND CONFIDENTIAL DATED 13 OCTOBER 2017 THE COMPANIES IDENTIFIED IN SCHEDULE 1 AS CHARGORS AND OXFORD FINANCE LLC AS COLLATERAL AGENT IP SECURITY AGREEMENT GREENBERG TRAURIG, LLP THE SHARD, LEVEL 8 32 LONDON BRIDGE STREET LONDON SE1 9SG STRICTLY PRIVATE AND CONFIDENTIAL TABLE OF CONTENTS 1. DEFINITIONS AND INTERPRETATION 2 2. PAYMENT OF SECURED LIABILITIES 7 3. |
|
| October 19, 2017 |
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-10.4 Exhibit 10.4 THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS THIRD AMENDMENT to Loan and Security Agreement (this Amendment) is entered into as of October 13, 2017 (the Third Amendment Date), by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (in its individual capacity, Oxford; and |
|
| October 19, 2017 |
EX-10.5 Exhibit 10.5 STRICTLY PRIVATE AND CONFIDENTIAL DATED 13 OCTOBER 2017 THE COMPANIES IDENTIFIED IN SCHEDULE 1 AS OBLIGORS AND OXFORD FINANCE LLC AS COLLATERAL AGENT DEED OF CONFIRMATION GREENBERG TRAURIG, LLP THE SHARD, LEVEL 8 32 LONDON BRIDGE STREET LONDON SE1 9SG STRICTLY PRIVATE AND CONFIDENTIAL TABLE OF CONTENTS 1. DEFINITIONS AND INTERPRETATION 3 2. CONFIRMATION 4 3. COUNTERPARTS 4 4. |
|
| October 19, 2017 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 October 13, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 No |
|
| October 19, 2017 |
EX-10.8 Exhibit 10.8 October 13, 2017 LOMBARD MEDICAL TECHNOLOGIES INC. 15420 Laguna Canyon Road, Suite 260 Irvine, CA 92618 ALTURA MEDICAL, INC. 923 Hamilton Ave. Menlo Park, CA 94025 Attn: Kurt Lemvigh, CEO Re: Success Fee Dear Kurt: This is the ?Success Fee Letter? referred to in that certain Loan and Security Agreement (as the amended, modified, supplemented or restated from time to time, the |
|
| October 19, 2017 |
INTELLECTUAL PROPERTY SECURITY AGREEMENT EX-10.7 Exhibit 10.7 INTELLECTUAL PROPERTY SECURITY AGREEMENT This Intellectual Property Security Agreement is entered into as October 13, 2017, by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (?Oxford?), as collateral agent (in such capacity, ?Collateral Agent?), the Lenders listed on Schedule 1.1 |
|
| October 19, 2017 |
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-10.3 Exhibit 10.3 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT THIS SECOND AMENDMENT to Loan and Security Agreement (this ?Amendment?) is entered into as of May 31, 2017 (the ?Second Amendment Date?), by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (in its individual capacity, ?Oxford?; and i |
|
| October 10, 2017 |
EX-99.1 Lombard Medical (NASDAQ: EVAR) October 2017 Exhibit 99.1 Disclaimer This presentation contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements are based on management?s current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially |
|
| October 10, 2017 |
Lombard Medical 6-K (Current Report of Foreign Issuer) 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 October 10, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not app |
|
| September 26, 2017 |
Exhibit 99.1 Lombard Medical?s New Delivery System for Aorfix? Endovascular Aortic Aneurysm Repair System Launched in Japan OXFORDSHIRE, England-(BUSINESS WIRE)-September 26, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular abdominal aortic aneurysm (AAA) endovascular repair products, today announced the full commercial launch in Japan of its new lo |
|
| September 26, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) 6-K 1 a51689075.htm LOMBARD MEDICAL, INC. 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 September 26, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant’s Na |
|
| September 20, 2017 |
Exhibit 99.1 Lombard Medical Appoints Jonathan Hornsby as Vice President, Sales & Marketing Veteran European Sales Manager of Endovascular Aneurysm Repair Market with Extensive Clinical and UK Experience OXFORDSHIRE, England-(BUSINESS WIRE)-September 20, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announce |
|
| September 20, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 September 20, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not appli |
|
| September 13, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 September 13, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not appli |
|
| September 13, 2017 |
Exhibit 99.1 Lombard Medical Announces Completion of Restructuring and Implementation of Strategic Plan to Achieve Profitability OXFORDSHIRE, England-(BUSINESS WIRE)-September 13, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced completion of a restructuring following the implementation of its new str |
|
| August 15, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) 6-K 1 a51669576.htm LOMBARD MEDICAL, INC. 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 August 15, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant’s Name |
|
| July 26, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 July 26, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant’s Name into English) Cayman Islands (State or Other Jur |
|
| July 26, 2017 |
Exhibit 99.1 June 26, 2017 Dear Shareholder: On behalf of the Board of Directors, I am pleased to invite you to the 2017 annual general meeting of shareholders of Lombard Medical, Inc. This letter serves as your official notice that the meeting will be held on August 10, 2017 at 12:00 noon, British Summer Time, at our U.K. office located at Lombard Medical House, 4 Trident Park, Didcot, Oxfordshir |
|
| June 13, 2017 |
EX-10.1 Exhibit 10.1 [On Lombard Medical, Inc. letterhead] Terms and Conditions of Employment (including particulars of terms of employment required by the Employment Rights Act 1996) EMPLOYER: Lombard Medical Limited, 4 Trident Park, Didcot, Oxon, OX11 7HJ, a subsidiary of Lombard Medical Inc., as a group, hereafter referred to as the ?Company? EMPLOYEE: Kurt Lemvigh, ADDRESS REDACTED 1 EMPLOYMEN |
|
| June 13, 2017 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 8, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not ap |
|
| May 15, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 15, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable |
|
| May 15, 2017 |
Exhibit 99.1 Lombard Medical Announces First Patient Enrolled and Treated in the ALTITUDE Registry for the Altura? Stent Graft System OXFORDSHIRE, U.K.-(BUSINESS WIRE)-May 15, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that it has enrolled and treated the first patient in its global registry to |
|
| May 10, 2017 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 9, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not app |
|
| May 4, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 4, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable ( |
|
| May 4, 2017 |
Exhibit 99.1 Lombard Medical?s Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium OXFORDSHIRE, U.K.-(BUSINESS WIRE)-May 4, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of endovascular stent graft systems, Altu |
|
| April 28, 2017 |
Form 20F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA |
|
| April 28, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 28, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicabl |
|
| April 21, 2017 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) 6-K 1 d346205d6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 20, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant’s Name into English) Cay |
|
| April 21, 2017 |
EX-10.1 Exhibit 10.1 March 27, 2017 Private & Confidential Mr. Kurt Lemvigh 22 Swan Walk Shepperton TW17 8LY United Kingdom Re: Offer Letter - sent via email to [email protected] Dear Kurt, On behalf of Lombard Medical, Inc. (the ?Company?), I am pleased to offer you employment with the Company conditioned only upon formal approval by the Company?s Board of Directors at the April 20, 2016 boar |
|
| April 20, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 20, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicabl |
|
| April 20, 2017 |
Lombard Medical Appoints New CEO Exhibit 99.1 Lombard Medical Appoints New CEO OXFORDSHIRE, England-(BUSINESS WIRE)-April 20, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Kurt Lemvigh has been appointed as its new Chief Executive Officer, effective immediately. Lemvigh is a veteran medical device executive with over 30 years |
|
| April 18, 2017 |
Lombard Medical Reports 2016 Fourth Quarter, Full Year Financial Results Exhibit 99.1 Lombard Medical Reports 2016 Fourth Quarter, Full Year Financial Results OXFORDSHIRE, U.K.-(BUSINESS WIRE)-April 18, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms, today reported financial results for the fourth quarter and year ended December 31, 2016. Recent Operational Highlights The signing |
|
| April 18, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 18, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicabl |
|
| April 18, 2017 |
Lombard Medical’s CEO Steps Down Exhibit 99.1 Lombard Medical’s CEO Steps Down OXFORDSHIRE, England-(BUSINESS WIRE)-April 18, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Simon Hubbert has stepped down from his position as CEO on April 18 after serving in the role for more than six years. A search is underway for a successor |
|
| April 18, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) 6-K 1 a51541793.htm LOMBARD MEDICAL, INC. 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 18, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant’s Name i |
|
| April 11, 2017 |
EVAR / Lombard Medical, Inc. / MicroPort Scientific CORP - SCHEDULE 13D/A Activist Investment microport20170407sc13da.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Lombard Medical, Inc. (Name of Issuer) Ordinary Shares, par value $0.01 per share (Title of Class of Securities) KYG555981094 (CUSIP Number) MicroPort Scientific Corporation 1601 Zhangdong Road Z.J. Hi-Tech Park Shanghai 20120 |
|
| April 11, 2017 |
ex1-1.htm Exhibit 1.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares of Lombard Medical, Inc. and that this Agreement be included as an Exhibit to such joint filin |
|
| April 3, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 3, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable |
|
| April 3, 2017 |
Exhibit 99.1 Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements Operational Foundation Established for Improved Gross Margins and Access to the Fast-Growing China Endovascular Market OXFORDSHIRE, U.K. & SHANGHAI-(BUSINESS WIRE)-April 3, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroP |
|
| February 10, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 10, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands (State or Other |
|
| February 7, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 7, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applica |
|
| February 7, 2017 |
EX-99.1 2 a51505777ex991.htm EXHIBIT 99.1 Exhibit 99.1 Lombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft OXFORDSHIRE, England-(BUSINESS WIRE)-February 7, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms |
|
| February 7, 2017 |
EVAR / Lombard Medical, Inc. / SVLSF IV, LLC - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LOMBARD MEDICAL, INC. (Name of Issuer) Ordinary Shares, par value $0.01 per share (Title of Class of Securities) G55598109 (CUSIP Number) December 31, 2016 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desi |
|
| January 23, 2017 |
EVAR / Lombard Medical, Inc. / Abingworth LLP - LOMBARD MEDICAL 13D/AM3 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 3) Under the Securities Exchange Act of 1934 LOMBARD MEDICAL, INC. (Name of Issuer) Ordinary Shares, $0.01 par value per share (Title of Class of Securities) G55598109 (CUSIP Number) John Heard Abingworth LLP Princes House 38 Jermyn Street London, England SW1Y 6DN +44 20 7534 1500 (Name, Address and |
|
| January 5, 2017 |
Exhibit 99.1 Lombard Medical Announces Regulatory Approval in Japan for IntelliFlex? LP Delivery System for the Aorfix? Abdominal Aortic Aneurysm Endovascular Stent Graft Exclusive Japanese Partner Medico?s Hirata Anticipates Market Share Gain Following Launch in Early 2017 OXFORDSHIRE, England-(BUSINESS WIRE)-January 5, 2017-Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused o |
|
| January 5, 2017 |
Lombard Medical LOMBARD MEDICAL, INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 5, 2017 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicab |
|
| December 28, 2016 |
EVAR / Lombard Medical, Inc. / MicroPort Scientific CORP - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Lombard Medical, Inc. (Name of Issuer) Ordinary Shares, par value $0.01 per share (Title of Class of Securities) KYG555981094 (CUSIP Number) MicroPort Scientific Corporation 1601 Zhangdong Road Z.J. Hi-Tech Park Shanghai 201203 P.R. China Phone: (86)(21) 38954600 Attention |
|
| December 28, 2016 |
ex1-1.htm Exhibit 1.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares of Lombard Medical, Inc. and that this Agreement be included as an Exhibit to such joint filin |
|
| December 28, 2016 |
EX-1.1 2 ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares of Lombard Medical, Inc. and that this Agreement be included as an Exhibi |
|
| December 28, 2016 |
EVAR / Lombard Medical, Inc. / MicroPort Scientific CORP - SCHEDULE 13D Activist Investment microport20161227sc13d.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Lombard Medical, Inc. (Name of Issuer) Ordinary Shares, par value $0.01 per share (Title of Class of Securities) KYG555981094 (CUSIP Number) MicroPort Scientific Corporation 1601 Zhangdong Road Z.J. Hi-Tech Park Shanghai 201203 P.R. China Phone: |
|
| December 19, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 December 18, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 N |
|
| December 19, 2016 |
EX-4.1 Exhibit 4.1 SUBORDINATION AGREEMENT This Subordination Agreement (the ?Agreement?) is made as of December 18, 2016, by and between MICROPORT NEUROTECH CHINA CORP. LIMITED, a corporation formed under the laws of Hong Kong with an office located at Level 54, Hopewell Center, 183 Queen?s Road East, Hong Kong (?Creditor?), and OXFORD FINANCE LLC, a Delaware limited liability company with an off |
|
| December 19, 2016 |
Exhibit 10.1 INVESTMENT AGREEMENT TABLE OF CONTENTS Page 1. Purchase and Sale of Ordinary Shares and Bonds 1 1.1 Sale and Issuance of Ordinary Shares 1 1.2 Sale of Convertible Bonds 1 1.3 Closing; Delivery 1 1.4 Use of Proceeds 2 1.5 Defined Terms Used in this Agreement 2 2. Representations and Warranties of the Company 5 2.1 Organization, Good Standing, Corporate Power and Qualification 5 2.2 Cap |
|
| December 19, 2016 |
EX-99.1 4 d313924dex991.htm EX-99.1 Exhibit 99.1 Lombard Medical and MicroPort Scientific Corporation Announce Strategic Partnership and Investment Agreement Oxfordshire, UK and Shanghai, China – December 19, 2016 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer a |
|
| December 5, 2016 |
EdgarFiling EXHIBIT 99.1 Positive Long-Term Data for Lombard Medical?s Aorfix? Endovascular Stent Graft System Confirms Sustained Performance in the Most Challenging Anatomies OXFORDSHIRE, United Kingdom, Dec. 05, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced |
|
| December 5, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 December 5, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number: 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 384 |
|
| November 21, 2016 |
EdgarFiling EXHIBIT 99.1 Multi-Centre Early Experience and Data Presented on Lombard Medical?s Altura? Endovascular Stent Graft at the 43rd Annual VEITHsymposium? UK - Manchester Group of Hospitals presented early experience and 100% technical success in 24 patients treated with Altura OXFORDSHIRE, United Kingdom, Nov. 21, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical devi |
|
| November 21, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 November 21, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number: 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 38 |
|
| November 15, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Receives NASDAQ Notice of Bid Price Deficiency No Immediate Effect on Listing – EVAR Has 180 Days to Regain Compliance OXFORDSHIRE, United Kingdom, Nov. 15, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), reported that on November 9, 2016, it re |
|
| November 15, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 November 15, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number: 001-36402 N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not appli |
|
| November 14, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces Scientific Presentations on Aorfix? and Altura? Endovascular Stent Grafts at the 43nd Annual VEITHsymposium? Debut of Data on New IntelliFlex? Delivery System and Clinical Experience with Altura OXFORDSHIRE, United Kingdom, Nov. 14, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneury |
|
| November 14, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 November 14, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number: 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 38 |
|
| November 11, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 November 10, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands (State or Other |
|
| November 11, 2016 |
EXHIBIT 99.1 |
|
| October 27, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 October 27, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| October 27, 2016 |
Lombard Medical Reports 2016 Third Quarter, Nine-Month Financial Results Exhibit 99.1 Lombard Medical Reports 2016 Third Quarter, Nine-Month Financial Results Irvine, CA ? October 27, 2016 ? Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported financial results for the third quarter and nine months ended September 30, 2016. Financial Results For the 2016 third |
|
| September 15, 2016 |
EVAR / Lombard Medical, Inc. / Invesco Ltd. - LOMBARD MEDICAL, INC Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Amendment No. 2) UNDER THE SECURITIES ACT OF 1934 Lombard Medical, Inc. (Name of Issuer) Ordinary Shares, par value $0.01 per share (Title and Class of Securities) KYG555981094 (CUSIP Number) Nancy Tomassone Invesco Ltd. 1555 Peachtree Street, N.E., Suite 1800 Atlanta, Georgia 30309 Telephone number: (404) 479-2926 (Name, Ad |
|
| August 22, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 August 22, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction o |
|
| August 22, 2016 |
EX-99.1 2 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives Commercial Restructuring Shifts Focus Exclusively to Europe, Japan and Key International Markets; Announces Process to Explore Strategic Alternatives to Maximize Shareholder Value Irvine, CA – August 22, 2016 – Lombard Medical, Inc. (N |
|
| August 22, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 August 22, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction o |
|
| August 22, 2016 |
EX-99.1 2 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives Commercial Restructuring Shifts Focus Exclusively to Europe, Japan and Key International Markets; Announces Process to Explore Strategic Alternatives to Maximize Shareholder Value Irvine, CA – August 22, 2016 – Lombard Medical, Inc. (N |
|
| August 12, 2016 |
EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Lombard Medical Reschedules 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date to August 22 to Provide Complete Information on Operational Initiatives IRVINE, Calif., Aug. 12, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal a |
|
| August 12, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 August 12, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number: 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 |
|
| August 11, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 August 11, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands (State or Other J |
|
| August 8, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 August 8, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number: 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 |
|
| August 8, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date IRVINE, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it will release its 2016 second quarter and six-mont |
|
| July 7, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 July 7, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands (State or Other Juri |
|
| July 7, 2016 |
Notice of Annual General Meeting of Shareholders Exhibit 99.1 Notice of Annual General Meeting of Shareholders July 7, 2016 Dear Shareholder: On behalf of the Board of Directors, I am pleased to invite you to the 2016 annual general meeting of shareholders of Lombard Medical, Inc. This letter serves as your official notice that the meeting will be held on August 2, 2016 at 10:00 a.m., Pacific Time, at our U.S. office located at 6440 Oak Canyon, |
|
| July 6, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 July 6, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number: 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 No |
|
| July 6, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Expands European Launch of its New Altura® Endograft System Multiple Patients Successfully Treated with Altura in the Netherlands and Spain IRVINE, Calif., July 06, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it |
|
| June 30, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces First Commercial Use of its New IntelliFlex? LP Delivery System for the Aorfix? Abdominal Aortic Aneurysm Endovascular Stent Graft IntelliFlex LP?s Lower Catheter Profile Expands Aorfix Treatment to More Patients IRVINE, Calif., June 30, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular A |
|
| June 30, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 30, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Juri |
|
| June 30, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 30, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Commission File Number 001-36402 N/A (Translation of Registrant?s Name into English) Cayman Islands (State or Other Jur |
|
| June 20, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 20, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Juri |
|
| June 20, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces CE Mark Approval for IntelliFlex? LP Delivery System for the Aorfix? Abdominal Aortic Aneurysm Endovascular Stent Graft New, Innovative Design Enhances Control and Precision During Placement with the Potential to Reduce Vessel Trauma IRVINE, Calif., June 20, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focu |
|
| June 16, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical to Initiate the Altura? ALTITUDE Global Registry to Evaluate the Treatment of Abdominal Aortic Aneurysms Across a Wide Range of ?Real-World? Endovascular Aneurysm Repair Interventions Paul Hayes, MD, FRCS, Endovascular Surgeon, University of Cambridge and Addenbrookes Hospital, Appointed as Principal Investigator IRVINE, Calif., June 16, 2016 (GLOBE NEWSWIR |
|
| June 16, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) 6-K 1 f6k061516.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 16, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (St |
|
| June 13, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Reports Positive Five-Year Aorfix? Endovascular Stent Graft Clinical Results in AAA Patients with Challenging Anatomy Aorfix Remains the Only Global On-Label Solution for Tortuous AAA Anatomy IRVINE, Calif., June 13, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdomi |
|
| June 13, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 13, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Juri |
|
| June 8, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Provides Update on Controlled Launch of the New Altura? Endovascular Stent Graft in Europe Controlled Launch Expanded to 37 Centers in the UK and Germany IRVINE, Calif., June 08, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ann |
|
| June 8, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 8, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Juris |
|
| June 7, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) 6-K 1 f6k060716.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 7, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (Sta |
|
| June 7, 2016 |
Lombard Medical to Present at the Jefferies 2016 Healthcare Conference EdgarFiling EXHIBIT 99.1 Lombard Medical to Present at the Jefferies 2016 Healthcare Conference IRVINE, Calif., June 07, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that CEO Simon Hubbert is scheduled to present at the Jefferies 2016 Healthcare Conference o |
|
| June 6, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Receives Australian Therapeutic Goods Administration (TGA) Approval for the Aorfix? Endovascular Stent Graft for the Treatment of Abdominal Aortic Aneurysms IRVINE, Calif., June 06, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today |
|
| June 6, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 6, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Juris |
|
| June 2, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces Scientific Presentation on Aorfix? Endovascular Stent Graft Five-Year Clinical Data at the 2016 Society for Vascular Surgery Annual Meeting IRVINE, Calif., June 02, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announc |
|
| June 2, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 June 2, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of I |
|
| May 31, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces Scientific Presentation by Leading Japanese Surgeons on Improving Endovascular Aneurysm Repair (EVAR) Treatment using the Aorfix? Endovascular Stent Graft at the 2016 Japanese Society for Vascular Surgery Annual Meeting in Tokyo, Japan IRVINE, Calif., May 31, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company foc |
|
| May 31, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) 6-K 1 f6k053116.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 31, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (Sta |
|
| May 24, 2016 |
Lombard Medical A (Current Report of Foreign Issuer) 6-K/A 1 lmi6ka0524.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 May 23, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Not applicable (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicab |
|
| May 23, 2016 |
Lombard Medical (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 May 2, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) Not applicable (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdi |
|
| May 19, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) 6-K 1 f6k051816.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 19, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (Sta |
|
| May 19, 2016 |
EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Lombard Medical Announces Scientific Presentation on Altura® and Aorfix™ Endovascular Stent Grafts at the International Symposium on Endovascular Therapeutics, SITE Update 2016 Broader European Launch Planned for New Altura Endovascular Stent Graft IRVINE, Calif., May 19, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device c |
|
| May 17, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 17, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Juris |
|
| May 17, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Releases Positive Early Results from the Altura? Endograft System Clinical Evaluation IRVINE, Calif., May 17, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the 30-day clinical results on 57 patients that were implanted |
|
| May 11, 2016 |
Lombard Medical Reports 2016 First Quarter Financial Results Exhibit 99.1 Lombard Medical Reports 2016 First Quarter Financial Results Irvine, CA ? May 11, 2016 ? Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported financial results and provided an operational update for the first quarter ended March 31, 2016. Q1 and Recent Operational Highlights ? |
|
| May 11, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 11, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of I |
|
| May 3, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 3, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of In |
|
| May 3, 2016 |
Lombard Medical Announces 2016 First Quarter Financial Results Release and Conference Call Date EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Lombard Medical Announces 2016 First Quarter Financial Results Release and Conference Call Date IRVINE, Calif., May 03, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it will release its 2016 first quarter fin |
|
| April 29, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| April 21, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 21, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jur |
|
| April 21, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces Scientific Presentations on Altura? and Aorfix? Endovascular Stent Grafts at the 38th Annual Charing Cross International Symposium Company exhibit to include a ?hands-on? learning center for new Altura Endovascular Stent Graft and Aorfix with the IntelliFlex LP Delivery System IRVINE, Calif., April 21, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. |
|
| April 18, 2016 |
EVAR / Lombard Medical, Inc. / Invesco Ltd. - LOMBARD MEDICAL INC Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Amendment No. 1) UNDER THE SECURITIES ACT OF 1934 Lombard Medical, Inc. (Name of Issuer) Ordinary Shares, par value $0.01 per share (Title and Class of Securities) KYG555981094 (CUSIP Number) Nancy Tomassone Invesco Ltd. 1555 Peachtree Street N.E., Suite 1800 Atlanta, Georgia 30309 Telephone number: (404) 479-2926 (Name, Addre |
|
| April 14, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 14, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jur |
|
| April 14, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Completes First Altura? Endovascular Stent Graft Live Case Training Workshop for German Physicians IRVINE, Calif., April 14, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it completed its first Altura? Endovascular Stent G |
|
| April 4, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 April 4, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Juri |
|
| April 4, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Provides Update on New Altura? Endovascular Stent Graft Launch Launch Reference Centers Continue to be Established in the UK and Germany IRVINE, Calif., April 04, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced an update on the c |
|
| March 16, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 March 16, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of |
|
| March 9, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 March 9, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Juri |
|
| March 9, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Completes First Altura? Endovascular Stent Graft Live Case Physician Training Workshop Event Featured Technical Review and Live Case Presentations IRVINE, Calif., March 09, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that the |
|
| March 3, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) 6-K 1 f6k030316.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 March 3, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (St |
|
| March 3, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical?s New Altura? Endovascular Stent Graft to be Presented at 9th Annual Houston Aortic Symposium Dainis Krievins, MD Will Present at Late Breaking AAA Presentation IRVINE, Calif., March 03, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today anno |
|
| February 26, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 26, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other |
|
| February 26, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Receives NASDAQ Notice of Bid Price Deficiency No Immediate Effect on Listing ? EVAR Has 180 Days to Regain Compliance IRVINE, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), reported that on February 24, 2016, it received a NAS |
|
| February 24, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 24, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| February 24, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces First Commercial Altura? Endovascular Stent Graft Procedure in Germany Following LINC Patient Successfully Treated Using the Revolutionary Altura Endovascular Stent Graft IRVINE, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms |
|
| February 24, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 24, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| February 22, 2016 |
EXHIBIT 99.1 Lombard Medical Reports 2015 Fourth Quarter, Full Year Financial Results Global 2015 Revenue Grew by 13.8% Over 2014; U.S. Revenue for the Year Grew 42.1% Over 2014 Irvine, CA ? February 22, 2016 ? Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported financial results and prov |
|
| February 22, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 22, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| February 16, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces 2015 Fourth Quarter and Year-End Financial Results Release and Conference Call Date IRVINE, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it will release its 2015 fourth quarter and year-e |
|
| February 16, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 16, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| February 12, 2016 |
EVAR / Lombard Medical, Inc. / LSP Advisory B.V. - SC 13G/A Passive Investment SC 13G/A 1 d123765dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) Lombard Medical, Inc. (Name of Issuer) Ordinary Shares (Title of Class of Securities) G55598109 (CUSIP Number) December 31, 2015 (Date of Event which Requires filing of this Statement) Check the appropriate box to de |
|
| February 10, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) 6-K 1 f6k021016.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 10, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable |
|
| February 5, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 5, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| February 5, 2016 |
EVAR / Lombard Medical, Inc. / AISLING CAPITAL III LP - AMENDMENT NO. 1 Passive Investment SC 13G/A 1 eh160025713ga1-lombard.htm AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Lombard Medical, Inc. (Name of Issuer) Ordinary Shares, par value $0.01 per share (Title of Class of Securities) KYG555981094 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of t |
|
| February 4, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces First Commercial Altura? Endovascular Stent Graft Procedure Patient Was Successfully Treated Using the Revolutionary Altura Endovascular Stent Graft IRVINE, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announc |
|
| February 4, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 4, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other J |
|
| January 29, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 29, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| January 28, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 28, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| January 27, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 27, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| January 27, 2016 |
EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Lombard Medical Announces Completion of Altura® Endovascular Stent Graft Live Case Presentation at the 12th Annual Leipzig Interventional Course (LINC) First Ever Live Case Presentation Highlighted Revolutionary Product Advantages IRVINE, Calif., Jan. 27, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on |
|
| January 27, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 27, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| January 25, 2016 |
January 25, 2016 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Amanda Ravitz, Assistant Director Re: Lombard Medical, Inc. Registration Statement on Form F-3 Filed January 13, 2016 File No. 333-208983 Dear Ms. Ravitz: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Lombard Medical, Inc. (the ?Company?) hereby respec |
|
| January 22, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 22, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| January 22, 2016 |
EVAR / Lombard Medical, Inc. / SVLSF IV, LLC - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* LOMBARD MEDICAL, INC. (Name of Issuer) Ordinary Shares, par value $0.01 per share (Title of Class of Securities) KYG555981094 (CUSIP Number) January 13, 2016 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desig |
|
| January 21, 2016 |
EdgarFiling EXHIBIT 99.1 Lombard Medical Announces First Ever Altura? Endovascular Stent Graft Live Clinical Case Presentation at the 12th Annual Leipzig Interventional Course (LINC) Scientific Presentations on Aorfix? and New Altura Stent Graft Systems Also Scheduled IRVINE, Calif., Jan. 21, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascu |
|
| January 21, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) EdgarFiling UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 21, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other J |
|
| January 14, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 14, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| January 13, 2016 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among Lombard Medical, Inc., Delta Merger Sub, Inc. Altura Medical, Inc., certain Stockholders of Altura Medical, Inc., and Shareholder Representative Services LLC, as Stockholders? Representative dated as of July 30, 2015 TABLE OF CONTENTS Page ARTICLE I DESCRIPTION OF TRANSACTION 2 Section 1.1 The Merger. 2 Section 1.2 Effect of the Merger. 2 Secti |
|
| January 13, 2016 |
As Filed With the Securities and Exchange Commission on January 13, 2016 Registration No. |
|
| January 12, 2016 |
EXHIBIT 99.1 Lombard Medical Announces 2015 Preliminary Revenue and Refocus of Commercial Organization for 2016 Product Launches IRVINE, Calif., Jan. 12, 2016 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced preliminary revenue for its fourth quarter and full year 20 |
|
| January 12, 2016 |
Lombard Medical (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 January 12, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| January 12, 2016 |
Lombard Medical (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 January 12, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| January 12, 2016 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 January 12, 2016 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| November 30, 2015 |
EX-99 2 newsrelease.htm PRESS RELEASE EXHIBIT 99.1 Three-Year Follow-Up Data From Lombard Medical Aorfix(TM) PYTHAGORAS Pivotal Trial Presented at 42nd Annual VEITHsymposium(TM) Longer-Term Positive Outcomes in Abdominal Aortic Aneurysm Patients With Standard and Challenging Anatomies Reinforce the Broad Clinical Value of Aorfix IRVINE, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc |
|
| November 30, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 November 30, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrants Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| November 24, 2015 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 November 24, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| November 18, 2015 |
EX-99 2 newsrelease.htm PRESS RELEASE EXHIBIT 99.1 Lombard Medical Announces Scientific Presentations on Aorfix(TM) and Altura(TM) Endovascular Stent Grafts at the 42nd Annual VEITHsymposium(TM) Debut of Data on New IntelliFlex(TM) Delivery System and Early Clinical Experience With Altura IRVINE, Calif., Nov. 18, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company |
|
| November 18, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 November 18, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or ot |
|
| November 12, 2015 |
Lombard Medical Announces Positive Results of First-in-Man Clinical Case Using New Low Profile IntelliFlex(TM) LP Delivery System to Deploy Aorfix(TM) Endovascular Stent Graft EXHIBIT 99. |
|
| November 12, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 November 12, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or ot |
|
| November 10, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 November 10, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or ot |
|
| November 10, 2015 |
EXHIBIT 99.1 Lombard Medical to Host VEITHsymposium(TM) Investor/Analyst Technology Workshop; Present at Upcoming Investor Conferences IRVINE, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that management will host a technology workshop for i |
|
| November 4, 2015 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 November 4, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| November 4, 2015 |
EXHIBIT 99.1 Lombard Medical Reports 2015 Third Quarter, Nine-Month Results Year-to-Date Aorfix Revenue Up 43 Percent Year-over-Year; Market Share in Japan Exceeds Five Percent in First Year of Sales Irvine, CA – November 4, 2015 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported finan |
|
| October 21, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 October 21, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or oth |
|
| October 21, 2015 |
Lombard Medical Announces 2015 Third Quarter and Nine-Month Financial Results Release and Conference Call Date EXHIBIT 99. |
|
| September 9, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 September 9, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or ot |
|
| September 9, 2015 |
EXHIBIT 99.1 Peer Reviewed Article Highlights Performance of the Lombard Medical Aorfix(TM) Endovascular Stent Graft in Treating Challenging Neck Anatomy Outcomes Similar to EVAR Trials With Less Challenging Anatomy IRVINE, Calif., Sept. 9, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneury |
|
| September 8, 2015 |
Lombard Medical Names David Milne to Board of Directors Lombard Medical Names David Milne to Board of Directors EXHIBIT 99.1 Lombard Medical Names David Milne to Board of Directors IRVINE, Calif., Sept. 8, 2015 (GLOBE NEWSWIRE) - Lombard Medical Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aortic repair of abdominal aortic aneurysms, today announced that medical device executive and investor David Milne has joined its Board of D |
|
| September 8, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 September 8, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or ot |
|
| September 1, 2015 |
400th Lombard Medical Aorfix(TM) Endovascular Stent Graft Procedure Completed One Year Following Japanese Approval and Launch EXHIBIT 99. |
|
| September 1, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 September 1, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or ot |
|
| August 5, 2015 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 August 5, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of |
|
| July 31, 2015 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 July 31, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of |
|
| July 31, 2015 |
[Lombard Medical, Inc. Logo] Notice of Annual General Meeting of Shareholders Exhibit 99.1 [Lombard Medical, Inc. Logo] Notice of Annual General Meeting of Shareholders July 17, 2015 Dear Shareholder: On behalf of the Board of Directors, I am pleased to invite you to the 2015 annual general meeting of shareholders of Lombard Medical, Inc. This letter serves as your official notice that the meeting will be held on August 18, 2015 at 10:00 a.m., Pacific Time, at our corporate |
|
| July 30, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 July 30, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other |
|
| July 30, 2015 |
Lombard Medical Acquires Endovascular Stent Graft Developer Altura Medical Lombard Medical Acquires Endovascular Stent Graft Developer Altura Medical EXHIBIT 99. |
|
| July 27, 2015 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lombard Medical Reports 2015 Second Quarter, Six-Month Results Revenue up 107 Percent Year-Over-Year; U.S. Sales Increase 123 Percent Irvine, CA ? July 27, 2015 ? Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported financial results and provided an opera |
|
| July 27, 2015 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 July 27, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of |
|
| July 20, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 July 20, 2015 Commission File Number: 001-36402 Lombard Medical, Inc. (Translation of registrant's name into English) 4 Trident Park Didcot Oxfordshire OX11 7HJ United Kingdom +44 (0)1235 750800 (Address of pri |
|
| July 20, 2015 |
EX-99 2 newsrelease.htm PRESS RELEASE EXHIBIT 99.1 Lombard Medical Announces 2015 Second Quarter and Six-Month Financial Results Release and Conference Call Date IRVINE, Calif., July 20, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it will release its 201 |
|
| June 30, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 June 30, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other |
|
| June 30, 2015 |
First Clinical Cases Performed Using Lombard Medical's Aorfix(TM) Plus Endovascular Stent Graft First Clinical Cases Performed Using Lombard Medical's Aorfix(TM) Plus Endovascular Stent Graft EXHIBIT 99. |
|
| June 17, 2015 |
Lombard Medical Set to Join Russell Microcap Index Lombard Medical Set to Join Russell Microcap Index EXHIBIT 99.1 Lombard Medical Set to Join Russell Microcap Index IRVINE, Calif., June 17, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), announced today that it is set to join the Russell Microcap Index at the conclusion of th |
|
| June 17, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 June 17, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other |
|
| June 2, 2015 |
Lombard Medical Enters Group Purchasing Agreement With Novation to Offer Aorfix(TM) Endovascular Stent Graft to More Than 100,000 Healthcare Institutions in the U. |
|
| June 2, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 June 2, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other j |
|
| May 26, 2015 |
Lombard Medical to Present at the Jefferies Global Healthcare Conference Lombard Medical to Present at the Jefferies Global Healthcare Conference EXHIBIT 99. |
|
| May 26, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 May 26, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other j |
|
| May 19, 2015 |
EX-99 2 newsrelease.htm PRESS RELEASE EXHIBIT 99.1 First Commercial Cases with Lombard Medical's AorFlex(TM) Delivery System for Endovascular Aneurysm Repair Performed in Japan AorFlex Delivery System Launched in Second Largest Standalone Endovascular Aneurysm Repair Market Through Exclusive Distribution Partner IRVINE, Calif., May 19, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a |
|
| May 19, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 May 19, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other j |
|
| May 12, 2015 |
Lombard Medical Reports 2015 First Quarter Results exh991.htm Exhibit 99.1 FOR IMMEDIATE RELEASE Lombard Medical Reports 2015 First Quarter Results Revenue up 66 Percent Year-Over-Year; U.S. Sales Increase 125 Percent Irvine, CA ? May 11, 2015 ? Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported financial results for the first quarter en |
|
| May 12, 2015 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) f6k051215.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 May 12, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jur |
|
| May 11, 2015 |
Lombard Medical Reports 2015 First Quarter Results Lombard Medical Reports 2015 First Quarter Results EXHIBIT 99.1 Lombard Medical Reports 2015 First Quarter Results Revenue Up 66 Percent Year-Over-Year; U.S. Sales Increase 125 Percent IRVINE, Calif., May 11, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported finan |
|
| May 11, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) 6-K 1 document.htm FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 May 11, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not |
|
| April 30, 2015 |
Form 20-F Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| April 30, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 April 30, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other |
|
| April 30, 2015 |
Lombard Medical to Present at Deutsche Bank Health Care Conference Lombard Medical to Present at Deutsche Bank Health Care Conference EXHIBIT 99.1 Lombard Medical to Present at Deutsche Bank Health Care Conference IRVINE, Calif., April 30, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that CEO Simon Hubbert is scheduled to pre |
|
| April 28, 2015 |
Lombard Medical Closes $26 Million Debt Facility With Oxford Finance Lombard Medical Closes $26 Million Debt Facility With Oxford Finance EXHIBIT 99.1 Lombard Medical Closes $26 Million Debt Facility With Oxford Finance IRVINE, Calif., April 28, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), announced that it has entered into a $26 million sec |
|
| April 28, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 April 28, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other |
|
| April 27, 2015 |
Lombard Medical Announces Live Case Presentation on Aorfix(TM) Endovascular Stent Graft at Charing Cross International Symposium EXHIBIT 99. |
|
| April 27, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 April 27, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other |
|
| April 22, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 April 22, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or other |
|
| April 22, 2015 |
Lombard Medical Enrolls First Patient in ARCHYTAS Global Clinical Registry Lombard Medical Enrolls First Patient in ARCHYTAS Global Clinical Registry EXHIBIT 99. |
|
| April 21, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) 6-K 1 document.htm FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 April 21, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 No |
|
| April 21, 2015 |
Lombard Medical Announces 2015 First Quarter Financial Results Release and Conference Call Date Lombard Medical Announces 2015 First Quarter Financial Results Release and Conference Call Date EXHIBIT 99. |
|
| April 15, 2015 |
Lombard Medical Initiates Post-Marketing Surveillance Program for Aorfix(TM) Endovascular Stent Graft EXHIBIT 99. |
|
| April 15, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) Form 6-K Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2015. Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable ( |
|
| March 17, 2015 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) 6-K 1 gff6k031715.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 March 17, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable |
|
| March 16, 2015 |
Lombard Medical FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 March 16, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant?s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of |
|
| March 13, 2015 |
Lombard Medical FORM 6-K FILING DOCUMENT (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 March 13, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrants Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction of |
|
| March 13, 2015 |
Lombard Medical Receives Regulatory Approval in Japan for AorFlex(TM) Endovascular Stent Graft Delivery System EXHIBIT 99. |
|
| March 4, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 March 4, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction of |
|
| March 2, 2015 |
Lombard Medical to Present at Upcoming Investor Conferences EXHIBIT 99.1 Lombard Medical to Present at Upcoming Investor Conferences IRVINE, Calif., March 2, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that CEO Simon Hubbert is scheduled to present at the following upcoming investor conferences: The ROTH Annual Confer |
|
| March 2, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 March 2, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction of |
|
| February 26, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 February 26, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| February 26, 2015 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Lombard Medical Reports 2014 Fourth Quarter, Full Year Financial Results Full Year Aorfix™ Revenue More than Doubled over 2013 Irvine, CA – February 26, 2015 – Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today reported operational progress and financial results |
|
| February 17, 2015 |
EXHIBIT 99.1 Lombard Medical Announces 2014 Fourth Quarter and Year-End Financial Results Release and Conference Call Date IRVINE, Calif. and LONDON, Feb. 17, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it will release its 2014 fourth quarter and year-en |
|
| February 17, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 February 17, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| February 11, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 February 11, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| February 11, 2015 |
Lombard Medical Appoints Michael H. Carrel to Its Board of Directors EXHIBIT 99.1 Lombard Medical Appoints Michael H. Carrel to Its Board of Directors IRVINE, Calif., Feb. 11, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that Michael H. Carrel has been appointed to the Company's Board of Directors. Mr. Carrel brings more than |
|
| February 5, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 February 5, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| February 5, 2015 |
EXHIBIT 99.1 Lombard Medical Receives FDA Approval for Aorfix(TM)Plus Endovascular Stent Graft Expanding Its Addressable Market IRVINE, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that the U.S. Food and Drug Administration (FDA) has approved |
|
| January 29, 2015 |
EXHIBIT 99.1 Lombard Medical Announces Successful Completion of Live EVAR Case With Aorfix(TM) Endovascular Stent Graft at 11th Annual Leipzig Interventional Course (LINC) 2015 IRVINE, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the success |
|
| January 29, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 January 29, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| January 27, 2015 |
Lombard Medical Initiates ARCHYTAS Global Clinical Registry EXHIBIT 99.1 Lombard Medical Initiates ARCHYTAS Global Clinical Registry Will Evaluate Clinical Outcomes of EVAR With Aorfix(TM) in Broad Cross-Section of AAA Patients IRVINE, Calif., Jan. 27, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the initiation of th |
|
| January 27, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 January 27, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| January 8, 2015 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT 6-K 1 document.htm FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 January 8, 2015 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 N |
|
| January 8, 2015 |
Lombard Medical Announces Preliminary 2014 Fourth Quarter and Full Year Revenues EXHIBIT 99.1 Lombard Medical Announces Preliminary 2014 Fourth Quarter and Full Year Revenues 2014 Global Aorfix(TM) Revenue More than Doubled Year-over-Year IRVINE, Calif., Jan. 8, 2015 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms (AAAs) and manufacturer of the Aorfix™ endovascular stent graf |
|
| December 19, 2014 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 December 19, 2014 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other (Primary Sta |
|
| December 17, 2014 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 December 17, 2014 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands (State or Other Jurisdiction of Incorporation or |
|
| December 16, 2014 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 December 16, 2014 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| December 1, 2014 |
Lombard Medical Appoints William J. Kullback as Chief Financial Officer EXHIBIT 99.1 Lombard Medical Appoints William J. Kullback as Chief Financial Officer Irvine, Calif. and LONDON, Dec. 1, 2014 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced the appointment of veteran finance and medical technology executive William J. Kullback as ch |
|
| December 1, 2014 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 December 1, 2014 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| December 1, 2014 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 December 1, 2014 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
|
| November 20, 2014 |
EXHIBIT 99.1 Lombard Medical Presents Two-Year Follow-Up Data From Aorfix(TM) PYTHAGORAS Pivotal Trial at 41st Annual VEITHsymposium Positive Outcomes in Abdominal Aortic Aneurysm Patients With Challenging Anatomies Reinforce Clinical Value of Aorfix IRVINE, Calif. and LONDON, Nov. 20, 2014 (GLOBE NEWSWIRE) - Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Ane |
|
| November 20, 2014 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 November 20, 2014 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or other jurisdiction |
|
| November 18, 2014 |
EVAR / Lombard Medical, Inc. 6-K - Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 November 18, 2014 Lombard Medical, Inc. (Exact Name of Registrant as Specified in Its Charter) N/A (Translation of Registrant’s Name into English) Cayman Islands 3841 Not applicable (State or Other Jurisdiction |
